[How Do We Integrate Advance Care Planning into Cancer Treatment?]

Q4 Medicine Japanese Journal of Cancer and Chemotherapy Pub Date : 2024-12-01
Yasuo Hirono, Takayoshi Tsubaki, Chihaya Takano, Serina Hani, Michiko Makino, Maiko Kodama
{"title":"[How Do We Integrate Advance Care Planning into Cancer Treatment?]","authors":"Yasuo Hirono, Takayoshi Tsubaki, Chihaya Takano, Serina Hani, Michiko Makino, Maiko Kodama","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the field of cancer care, it is still difficult to say that advance care planning(ACP)has been fully integrated, and the perceptions of ACP vary depending on the individual's role. Since oncologists have a deeper understanding of the patient's condition and prognosis than the patients themselves, they are often the first to recognize the future need for ACP. It is important to gather and incorporate patients' preferences and relevant information regarding ACP early in the course of daily cancer treatment. However, many oncologists and medical staffs still lack sufficient understanding of ACP or find it difficult because they do not understand the procedure. To address this, we have established an in-hospital working group to organize how to share information with medical staff, such as nurses, who play a crucial role in ACP. While many oncologists find it difficult to deliver bad news to patients, oncologists are the only ones who can introduce ACP at the appropriate time. With the advent of cancer genomic medicine, there have been cases where patients, previously considered terminal under conventional care, have gained new opportunities for improvement. It is essential to integrate ACP into cancer care by recognizing the unique advantage oncologists have in adapting to the rapid changes in cancer treatment.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 12","pages":"1186-1190"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In the field of cancer care, it is still difficult to say that advance care planning(ACP)has been fully integrated, and the perceptions of ACP vary depending on the individual's role. Since oncologists have a deeper understanding of the patient's condition and prognosis than the patients themselves, they are often the first to recognize the future need for ACP. It is important to gather and incorporate patients' preferences and relevant information regarding ACP early in the course of daily cancer treatment. However, many oncologists and medical staffs still lack sufficient understanding of ACP or find it difficult because they do not understand the procedure. To address this, we have established an in-hospital working group to organize how to share information with medical staff, such as nurses, who play a crucial role in ACP. While many oncologists find it difficult to deliver bad news to patients, oncologists are the only ones who can introduce ACP at the appropriate time. With the advent of cancer genomic medicine, there have been cases where patients, previously considered terminal under conventional care, have gained new opportunities for improvement. It is essential to integrate ACP into cancer care by recognizing the unique advantage oncologists have in adapting to the rapid changes in cancer treatment.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
我们如何将预先护理计划整合到癌症治疗中?]
在癌症护理领域,目前还很难说预先护理计划(advance care planning, ACP)已经得到了充分的整合,对ACP的认知也因个体角色的不同而不同。由于肿瘤学家比患者本身更了解患者的病情和预后,他们通常是第一个认识到未来需要ACP的人。在日常癌症治疗过程的早期收集和纳入患者的偏好和有关ACP的相关信息是很重要的。然而,许多肿瘤学家和医务人员仍然对ACP缺乏足够的了解,或者因为不了解手术过程而感到困难。为了解决这一问题,我们成立了一个院内工作组,组织如何与在ACP中发挥关键作用的医务人员(如护士)共享信息。虽然许多肿瘤学家发现很难向患者传达坏消息,但只有肿瘤学家才能在适当的时候介绍ACP。随着癌症基因组医学的出现,以前被认为接受常规治疗的晚期患者获得了新的改善机会。认识到肿瘤学家在适应癌症治疗快速变化方面的独特优势,将ACP纳入癌症治疗是至关重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
期刊最新文献
[Online Survey about Communication between Abemaciclib-Treated Patients with Breast Cancer and Physicians]. [Survey on the Size of Oral Anticancer Drugs]. [Ⅰ. Personalized Perioperative Therapy in Luminal Breast Cancer]. [Ⅱ. Recurrence Score in Patients with BRCA1/2 Mutation from the OlympiA and TAILORx Trial Results]. [Ⅲ. MONARCH-E and Oncotype DX].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1